These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31826488)

  • 1. Microcrystalline cellulose as an effective crystal growth inhibitor for the ternary Ibrutinib formulation.
    Zhang M; Suo Z; Peng X; Gan N; Zhao L; Tang P; Wei X; Li H
    Carbohydr Polym; 2020 Feb; 229():115476. PubMed ID: 31826488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable nanoparticles from prosopisylated cellulose as a platform for enhanced oral bioavailability of poorly water-soluble drugs.
    Kenechukwu FC; Dias ML; Ricci-Júnior E
    Carbohydr Polym; 2021 Mar; 256():117492. PubMed ID: 33483021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Self-Assembled Ibrutinib-Phospholipid Complex for Potently Peroral Delivery of Poorly Soluble Drugs with pH-Dependent Solubility.
    Qiu Q; Lu M; Li C; Luo X; Liu X; Hu L; Liu M; Zheng H; Zhang H; Liu M; Lai C; Song Y; Deng Y
    AAPS PharmSciTech; 2018 Nov; 19(8):3571-3583. PubMed ID: 30209789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of ethyl cellulose, microcrystalline cellulose and octadecanol for wax based floating solid dispersion pellets.
    Yan HX; Zhang SS; He JH; Liu JP
    Carbohydr Polym; 2016 Sep; 148():143-52. PubMed ID: 27185125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability enhancement and pharmacokinetic profile of an anticancer drug ibrutinib by self-nanoemulsifying drug delivery system.
    Shakeel F; Iqbal M; Ezzeldin E
    J Pharm Pharmacol; 2016 Jun; 68(6):772-80. PubMed ID: 27018771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QbD based development of proliposome of lopinavir for improved oral bioavailability.
    Patel GM; Shelat PK; Lalwani AN
    Eur J Pharm Sci; 2017 Oct; 108():50-61. PubMed ID: 27586019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downstream drug product processing of itraconazole nanosuspension: Factors influencing tablet material properties and dissolution of compacted nanosuspension-layered sugar beads.
    Tan EH; Parmentier J; Low A; Möschwitzer JP
    Int J Pharm; 2017 Oct; 532(1):131-138. PubMed ID: 28859940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallization, structural relaxation and thermal degradation in Poly(L-lactide)/cellulose nanocrystal renewable nanocomposites.
    Lizundia E; Vilas JL; León LM
    Carbohydr Polym; 2015 Jun; 123():256-65. PubMed ID: 25843857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid microcrystalline dispersion films as a new strategy to improve the dissolution rate of poorly water soluble drugs: A case study using olanzapine.
    Modica de Mohac L; de Fátima Pina M; Raimi-Abraham BT
    Int J Pharm; 2016 Jul; 508(1-2):42-50. PubMed ID: 27154255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of daidzein nanosuspensions: Preparation, characterization, in vitro evaluation, and pharmacokinetic analysis.
    Wang H; Xiao Y; Wang H; Sang Z; Han X; Ren S; Du R; Shi X; Xie Y
    Int J Pharm; 2019 Jul; 566():67-76. PubMed ID: 31125715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
    Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
    Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
    Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
    Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders - Part I.
    Meruva S; Thool P; Shah S; Karki S; Bowen W; Ghosh I; Kumar S
    Int J Pharm; 2019 Sep; 568():118189. PubMed ID: 30851385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by kinase inhibitors: Effects of dabrafenib, ibrutinib, nintedanib, trametinib and BIBF 1202.
    Korprasertthaworn P; Chau N; Nair PC; Rowland A; Miners JO
    Biochem Pharmacol; 2019 Nov; 169():113616. PubMed ID: 31445021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the Solubility, Dissolution, and Bioavailability of Ibrutinib by Preparing It in a Coamorphous State With Saccharin.
    Shi X; Song S; Ding Z; Fan B; Huang W; Xu T
    J Pharm Sci; 2019 Sep; 108(9):3020-3028. PubMed ID: 31067482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcrystalline cellulose, a direct compression binder in a quality by design environment--a review.
    Thoorens G; Krier F; Leclercq B; Carlin B; Evrard B
    Int J Pharm; 2014 Oct; 473(1-2):64-72. PubMed ID: 24993785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of cellulose fibers on the formation of heterocyclic aromatic amines in grilled beef patties.
    Gibis M; Weiss J
    Food Chem; 2017 Aug; 229():828-836. PubMed ID: 28372250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Joint action of ultrasonic and Fe³⁺ to improve selectivity of acid hydrolysis for microcrystalline cellulose.
    Li J; Qiang D; Zhang M; Xiu H; Zhang X
    Carbohydr Polym; 2015 Sep; 129():44-9. PubMed ID: 26050886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel cellulose-based amorphous solid dispersions enhance quercetin solution concentrations in vitro.
    Gilley AD; Arca HC; Nichols BLB; Mosquera-Giraldo LI; Taylor LS; Edgar KJ; Neilson AP
    Carbohydr Polym; 2017 Feb; 157():86-93. PubMed ID: 27988001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the impact of microcrystalline cellulose physicochemical properties on tabletability.
    Thoorens G; Krier F; Rozet E; Carlin B; Evrard B
    Int J Pharm; 2015 Jul; 490(1-2):47-54. PubMed ID: 25981619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.